Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-29 @ 11:54 PM
Study NCT ID:
NCT07307235
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-12-29
First Post:
2025-11-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents
Sponsor:
Shanghai Zhongshan Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-12-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2025-11-28
First Submit QC Date:
None
Study First Post Date:
2025-12-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-14
Last Update Post Date:
2025-12-29
Last Update Post Date Type:
ACTUAL